Monday, January 9, 2012

Resistant Vaginal Yeast Infections on the Rise

Candida vaginal infections have been treated with newer drugs in recent years and resistance has developed. Studies have shown that the old standby, nystatin, might be more effective. Nystatin also has the advantage that it is not absorbed well, so systemic side effects are rare. Whether we treat localized vaginal infections or yeast imbalance in the digestive tract, which can affect the entire body from release of toxins, we find that a comprehensive approach is often needed. That might include a yeast-control diet, probiotics, at least two anti-yeast agents and sometimes a homeopathic to stimulate the immune system. See Family Practice News,(click here) October 1, 2011, p. 28, report on the annual meeting of the Infectious Diseases Society for OB-GYN.

No comments: